ACZ885 in Type 1 Diabetes Mellitus
NCT01322321 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2012-09-05
Summary
This study will assess the safety and efficacy of ACZ885 on stimulated C-peptide during a mixed meal test in patients with newly-diagnosed type 1 diabetes mellitus.
Conditions
- Diabetes Mellitus
- Diabetes Type 1
Interventions
- DRUG
-
ACZ885
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2011-06-30
Countries
- United States
- Canada
- Germany
- United Kingdom
Study Locations
More Related Trials
-
A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
NCT02703324 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes
NCT06685185 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells
NCT01068951 ·Status: COMPLETED ·Phase: NA
-
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
NCT06981234 ·Status: RECRUITING ·Phase: PHASE2
-
Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)
NCT02620332 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection
NCT07051564 ·Status: RECRUITING ·Phase: NA
-
Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes
NCT01536431 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes
NCT01784211 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes
NCT00487240 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes
NCT04712266 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
NCT03056456 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes
NCT01769404 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
NCT00553488 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.
NCT02103595 ·Status: COMPLETED ·Phase: NA
-
Effects of XOMA 052 on Insulin Production in Type 1 Diabetes
NCT01788033 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
NCT04585776 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
NCT02146651 ·Status: COMPLETED ·Phase: PHASE2
-
Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)
NCT05660941 ·Status: RECRUITING ·Phase: NA
-
Dose-Exposure-Response in Type 1 Diabetes Mellitus
NCT00368394 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
NCT03849612 ·Status: COMPLETED ·Phase: NA
-
Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients
NCT01120444 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Acetazolamide in Persons With Type 1 Diabetes - Dose Finding
NCT05473364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin
NCT00358553 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes
NCT02612844 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin Pump
NCT06809621 ·Status: COMPLETED ·Phase: PHASE1